about
A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cellsMurine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells.Megadose stem cell administration as a route to mixed chimerism.The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.The evolution of T-cell depletion in haploidentical stem-cell transplantation.Exercising 'veto' power to make haploidentical hematopoietic stem cell transplantation a safe modality for induction of immune tolerance.Towards 'off-the-shelf' genetically modified T cells: prolonging functional engraftment in mice by CD8 veto T cells.Molecular signature of Epstein-Barr virus infection in MS brain lesions.Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamideVeto cells for safer nonmyeloablative haploidentical HSCT and CAR T cell therapy
P50
Q35743874-25B2D930-7991-410A-B6A3-A7970B0B752EQ35743914-2961BBE4-F199-4CF7-A2B1-287C30B830D1Q38218154-C5489574-4504-49E7-872B-0F2AFA64A999Q38514485-5D663F5B-79A0-4784-86AB-4920D58817C1Q38673780-3DC649A2-4820-43BE-AE75-2D1024FB9BA9Q48039446-C07BF2AF-8121-45E4-9B73-141423D4F2BEQ49900872-D0DD5FD2-578A-45C4-BA21-E7B1442BE3BBQ55128564-96239794-BC17-4BD3-9727-B2106B65E773Q61050854-949B572C-C2BC-4B11-9B06-CC16C50F908BQ92768990-25E89A21-98D7-46FB-80AB-D818E3BBFDD7
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
N Or-Geva
@en
N Or-Geva
@nl
type
label
N Or-Geva
@en
N Or-Geva
@nl
prefLabel
N Or-Geva
@en
N Or-Geva
@nl
P31
P496
0000-0001-9631-3818